Celltrion and LISCure Biosciences to develop unique microbiome treatment for Parkinson’s disease News Celltrion and LISCure Biosciences to develop unique microbiome treatment for Parkinson’s disease Gauri Kurdukar February 23, 2023 LISCure Biosciences Inc., a clinical-stage biotech is developing advanced microbiome technology with accurate targets and announced a multi-year... Read More Read more about Celltrion and LISCure Biosciences to develop unique microbiome treatment for Parkinson’s disease
